Remote ischemic preconditioning for prevention of contrast-induced nephropathy – A randomized control trial
Background: There is a lack of sufficient data regarding the protective effects of remote ischemic preconditioning (RIPC) in patients at risk of developing contrast-induced nephropathy (CIN). Thus, this study was conducted to determine whether RIPC as an adjunct to standard therapy prevents CIN in h...
Main Authors: | Akshay Ashok Bafna, Hetan C. Shah |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-07-01
|
Series: | Indian Heart Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0019483220300833 |
Similar Items
-
The Impact of Remote Ischemic Pre-Conditioning on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography and Angioplasty: A Double-Blind Randomized Clinical Trial
by: Arash Gholoobi, et al.
Published: (2015-12-01) -
Uric acid and contrast-induced nephropathy: an updated review and meta-regression analysis
by: Francesco Pelliccia, et al.
Published: (2018-12-01) -
Safe Limits of Contrast Media for Contrast-Induced Nephropathy: A Multicenter Prospective Cohort Study
by: Zhiqiang Nie, et al.
Published: (2021-08-01) -
Comparison between rosuvastatin and atorvastatin for the prevention of contrast-induced nephropathy in patients with STEMI undergoing primary percutaneous coronary intervention
by: Ata Firouzi, et al.
Published: (2018-09-01) -
Incidence, Risk Factors, and Outcomes of Contrast Associated Nephropathy following Percutaneous Coronary Intervention
by: Iqbal Wani, et al.
Published: (2020-01-01)